EX-10.14



 Exhibit 10.14 

July 18, 2016 
 Via Email 

Robert Hoffman 
  

	 	Re:	Terms of Resignation and Transition 

 Dear Robert: 

This letter confirms the agreement (“Agreement”) between you and AnaptysBio, Inc. (the
“Company”) concerning the terms of your transition and separation from employment and offers you certain benefits to which you would not otherwise be entitled, conditioned upon your provision of a general release of claims
and covenant not to sue and your other promises herein. If you agree to the terms outlined herein, please sign and return this Agreement to me in the timeframe outlined below. 

1. Resignation: You have expressed your intent to voluntarily resign your employment with the Company, and following discussions on such
matter, you and the Company have agreed that, in lieu of the Company’s accepting your resignation pursuant to the thirty day timeframe set forth in Section 4.2 of your July 13, 2015 Employment Agreement with the Company, as amended
(the “Employment Agreement”), the Company will continue your employment through the Transition Period (as defined below). 

2. Continued Employment; Other Release Consideration: In exchange for your agreement to the general release and waiver of claims and
covenant not to sue set forth below and your other promises herein, you and the Company agree to continue your employment on the following terms: 

a. Resignation Date; Transition Period and Services: Your last day of employment with the Company will be October 31, 2016 (the
“Resignation Date”). Between now and the Resignation Date (the “Transition Period”), you agree to carry out the duties and responsibilities of your position as directed principally by Hamza Suria, the
Company’s Chief Executive Officer, to whom you will continue to report, and to provide other transition services as may reasonably be requested by the Company, including (a) assistance with review of financial statements for the second
quarter of 2016 and filing of an amendment to the Company’s registration statement on Form S-1 incorporating such financial statements, subject to review and completion of such financial statements and amendment, which amendment you would
execute 








 Robert Hoffman 

 Page 
 2
 
  

 
in your capacity as Chief Financial Officer provided that the Company is prepared to file such amendment and the Chief Executive Officer of the Company also executes such amendment in his
capacity as Chief Executive Officer and (b) transition of the responsibilities, duties, and knowledge relative to your position to one or more individuals designated by the Company (the “Transition Services”). During the
Transition Period: (i) you will continue to be present in the office and maintain a full-time schedule; (ii) you may use regular business hours to pursue future plans and/or other employment opportunities, so long as such activities do not
materially conflict with the Transition Services; and (iii) you will continue to be bound by all applicable common law and contractual duties of loyalty and with respect to protection of the Company’s trade secrets and other proprietary
business information, including as set forth in Section 2 of the Employment Agreement and in Exhibit A hereto. Notwithstanding the foregoing, you may elect to terminate the Transition Period early by written notice to the Company, in which case
the termination date you specify (which shall be at least two weeks after the date of your notice to the Company) will constitute the “Resignation Date” for purposes of this letter, including with regarding to vesting and exercise of your
Options as described in Section 6. 
 b. Compensation and Benefits: During the Transition Period, the Company will continue to
pay you your current base salary and you will continue to be eligible to participate in benefits customarily afforded to other Company executives, including participation in the Company-sponsored health benefits plan and continued vesting of your
stock options, to the fullest extent allowed by the governing plans, agreements, or policies. 
 By signing below, you acknowledge that you
are receiving the release consideration outlined in this paragraph in consideration for waiving your rights to claims referred to in this Agreement, and that you would not otherwise be entitled to the release consideration. 

3. Final Pay: On the Resignation Date, the Company will pay you for all wages, salary, bonuses, commissions, reimbursable expenses,
accrued vacation and any similar payments due you from the Company as of the Resignation Date. By signing below, you acknowledge that the Company does not owe you any other amounts. 

4. Return of Company Property: You hereby warrant to the Company that, no later than the Resignation Date, you will return to the
Company all property or data of the Company of any type whatsoever that has been in your possession or control. 
 5. Proprietary
Information: You hereby acknowledge that you are bound by the attached Confidential Information and Invention Assignment Agreement, (attached as Exhibit A hereto) and that as a result of your employment with the Company you have had
access to the Company’s Confidential Information (as defined in Exhibit A), that you will hold all Confidential Information in strictest confidence and that you will not make use of such Confidential Information on behalf of anyone,
except as required in the course of your employment with the Company. You further confirm that you will deliver to the Company, no later than the Resignation Date, all documents and data of any nature containing or pertaining to such Confidential
Information and that you will not take with you any such documents or data or any reproduction thereof. 








 Robert Hoffman 

 Page 
 3
 
  

 6. Stock Options: Pursuant to (i) that certain Option Grant Notice between you
and the Company dated August 14, 2015 for the purchase of up to 350,015 shares of the Company’s common stock, (ii) that certain Option Grant Notice between you and the Company dated August 14, 2015 for the purchase of up to
404,040 shares of the Company’s common stock, (iii) that certain Option Grant Notice between you and the Company dated August 14, 2015 for the purchase of up to 432,032 shares of the Company’s common stock and (iv) the
Company’s 2016 Equity Incentive Plan (hereafter collectively referred to as the “Stock Option Agreements”), you were granted the option to purchase up to an aggregate of 1,186,087 shares of the Company’s common
stock (the “Options”). As of the date of this letter, the Options have vested as to 188,513 shares (the “Vested Shares”) and remain unvested as to 997,574 shares (the “Unvested
Shares”). During the Transition Period, the Options will continue to vest according to the terms of the Stock Option Agreements; however, all vesting will cease as of the Resignation Date. At all times, your rights concerning the
Options will continue to be governed by the Stock Option Agreements. Per the Stock Option Agreements, you will have 180 days following the Resignation Date to exercise any then-vested shares; after that date, you will no longer have a right to
exercise the Options as to any shares. 
 7. General Release and Waiver of Claims: 

a. The payments and promises set forth in this Agreement are in full satisfaction of all accrued salary, vacation pay, bonus and commission
pay, profit-sharing, stock, stock options or other ownership interest in the Company, termination benefits or other compensation to which you may be entitled by virtue of the Employment Agreement, your
employment with the Company and/or your separation from the Company. To the fullest extent permitted by law, you hereby release and waive any other claims you may have against the Company and its owners, agents, officers, shareholders, employees,
directors, attorneys, subscribers, subsidiaries, affiliates, successors and assigns (collectively “Releasees”), whether known or not known, including, without limitation, claims of any kind under the Employment Agreement
(including for severance or benefits of any kind), claims under any employment laws, including, but not limited to, claims of unlawful discharge, breach of contract, breach of the covenant of good faith and fair dealing, fraud, violation of public
policy, defamation, physical injury, emotional distress, claims for additional compensation or benefits arising out of your employment or your separation of employment, claims under Title VII of the 1964 Civil Rights Act, as amended, the California
Fair Employment and Housing Act and any other laws and/or regulations relating to employment or employment discrimination, including, without limitation, claims based on age or under the Age Discrimination in Employment Act or Older Workers Benefit
Protection Act, and/or claims based on disability or under the Americans with Disabilities Act. For clarity, following the Effective Date and by virtue of the foregoing release, the terms of your employment during the Transition Period will be
governed solely by this Agreement, and the terms of your Employment Agreement will no longer apply. 








 Robert Hoffman 

 Page 
 4
 
  

 b. By signing below, you expressly waive any benefits of Section 1542 of the Civil Code
of the State of California, which provides as follows: 
 “A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE
CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.” 

c. You and the Company do not intend to release claims that you may not release as a matter of law, including but not limited to claims for
indemnity under California Labor Code Section 2802, the Company’s certificate of incorporation and bylaws and/or any contractual agreements for indemnification between you and the Company, or any claims for enforcement of this Agreement.
To the fullest extent permitted by law, any dispute regarding the scope of this general release shall be determined by an arbitrator under the procedures set forth in the arbitration clause below. 

8. Covenant Not to Sue: 

a. To the fullest extent permitted by law, at no time subsequent to the execution of this Agreement will you pursue, or cause or knowingly
permit the prosecution, in any state, federal or foreign court, or before any local, state, federal or foreign administrative agency, or any other tribunal, of any charge, claim or action of any kind, nature and character whatsoever, known or
unknown, which you may now have, have ever had, or may in the future have against Releasees, which is based in whole or in part on any matter released by this Agreement. 

b. Nothing in this paragraph shall prohibit you from filing a charge or complaint with a government agency where, as a matter of law, the
parties may not restrict your ability to file such administrative complaints. However, you understand and agree that, by entering into this Agreement, you are releasing any and all individual claims for relief, and that any and all subsequent
disputes between you and the Company shall be resolved through arbitration as provided below. 
 c. Nothing in this paragraph shall prohibit
or impair you or the Company from complying with all applicable laws, nor shall this Agreement be construed to obligate either party to commit (or aid or abet in the commission of) any unlawful act. 

9. Nondisparagement: You agree that you will not disparage Releasees or their products, services, agents, representatives, directors,
officers, shareholders, attorneys, employees, vendors, affiliates, successors or assigns, or any person acting by, through, under or in concert with any of them, with any written or oral statement. The Company agrees that none of its executive
officers or directors will make any disparaging statement, written or oral, regarding your service to or relationship with the Company. Nothing in this paragraph shall prohibit you or the Company from providing truthful information in response to a
subpoena or other legal process. 








 Robert Hoffman 

 Page 
 5
 
  

 10. Arbitration: Except for any claim for injunctive relief arising out of a breach of
a party’s obligations to protect the other’s proprietary information, the parties agree to arbitrate, in San Diego, California through JAMS, any and all disputes or claims arising out of or related to the validity, enforceability,
interpretation, performance or breach of this Agreement, whether sounding in tort, contract, statutory violation or otherwise, or involving the construction or application or any of the terms, provisions, or conditions of this Agreement. Any
arbitration may be initiated by a written demand to the other party. The arbitrator’s decision shall be final, binding, and conclusive. The parties further agree that this Agreement is intended to be strictly construed to provide for
arbitration as the sole and exclusive means for resolution of all disputes hereunder to the fullest extent permitted by law. The parties expressly waive any entitlement to have such controversies decided by a court or a jury. 

11. Attorneys’ Fees: If any action is brought to enforce the terms of this Agreement, the prevailing party will be entitled to
recover its reasonable attorneys’ fees, costs and expenses from the other party, in addition to any other relief to which the prevailing party may be entitled. 

12. Confidentiality: The contents, terms and conditions of this Agreement must be kept confidential by you and may not be disclosed
except to your immediate family, accountant or attorneys or pursuant to subpoena or court order. You agree that if you are asked for information concerning this Agreement, you will state only that you and the Company reached an amicable resolution
of any disputes concerning your separation from the Company. Any breach of this confidentiality provision shall be deemed a material breach of this Agreement. 

13. No Admission of Liability: This Agreement is not and shall not be construed or contended by you to be an admission or evidence of
any wrongdoing or liability on the part of Releasees, their representatives, heirs, executors, attorneys, agents, partners, officers, shareholders, directors, employees, subsidiaries, affiliates, divisions, successors or assigns. This Agreement
shall be afforded the maximum protection allowable under California Evidence Code Section 1152 and/or any other state or federal provisions of similar effect. 

14. Complete and Voluntary Agreement: This Agreement, together with Exhibit A hereto and the Stock Option Agreements, constitute the
entire agreement between you and Releasees with respect to the subject matter hereof and supersedes all prior negotiations and agreements, whether written or oral, relating to such subject matter, including the terms of your Employment Agreement.
You acknowledge that neither Releasees nor their agents or attorneys have made any promise, representation or warranty whatsoever, either express or implied, written or oral, which is not contained in this Agreement for the purpose of inducing you
to execute the Agreement, and you acknowledge that you have executed this Agreement in reliance only upon such promises, representations and warranties as are contained herein, and that you are executing this Agreement voluntarily, free of any
duress or coercion. 
 15. Severability: The provisions of this Agreement are severable, and if any part of it is found to be
invalid or unenforceable, the other parts shall remain fully valid and enforceable. Specifically, should a court, arbitrator, or government agency conclude that a particular claim may not be released as a matter of law, it is the intention of the
parties that the general release, the waiver of unknown claims and the covenant not to sue above shall otherwise remain effective to release any and all other claims. 








 Robert Hoffman 

 Page 
 6
 
  

 16. Modification; Counterparts; Facsimile/PDF Signatures: It is expressly agreed that
this Agreement may not be altered, amended, modified, or otherwise changed in any respect except by another written agreement that specifically refers to this Agreement, executed by authorized representatives of each of the parties to this
Agreement. This Agreement may be executed in any number of counterparts, each of which shall constitute an original and all of which together shall constitute one and the same instrument. Execution of a facsimile or PDF copy shall have the same
force and effect as execution of an original, and a copy of a signature will be equally admissible in any legal proceeding as if an original. 

17. Governing Law: This Agreement shall be governed by and construed in accordance with the laws of the State of California. 

18. Review of Resignation Agreement: You understand that you may take up to twenty-one (21) days to consider this Agreement and, by
signing below, affirm that you were advised to consult with an attorney prior to signing this Agreement. You also understand you may revoke this Agreement within seven (7) days of signing this document and that the Transition period and
compensation and benefits thereunder are expressly conditioned upon this Agreement becoming effective without revocation. 
 19. Effective
Date: This Agreement is effective on the eighth (8th) day after you sign it provided you have not revoked the Agreement as of that time. 

If you agree to abide by the terms outlined in this letter, please sign this letter below return it to me within the timeframe noted above. I
wish you the best in your future endeavors. 
  

			
	Sincerely,
	
	ANAPTYSBIO, INC.
		
	By:	 	/s/ Hamza Suria
	Name:	 	 Hamza Suria

	Title:	 	 President and CEO



 READ, UNDERSTOOD AND AGREED 
  

					
	 /s/ Robert Hoffman
	 	Date:	 	
  7/21/16                  
      

	Robert Hoffman	 		 	








 EXHIBIT A 

CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT 







 



 
 PROPRIETARY INFORMATION 

AND INVENTIONS AGREEMENT 

As a condition of my employment with AnaptysBio, Inc., its subsidiaries, affiliates, successors or assigns (together, the
“Company”), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter paid to me by Company, I agree to the following: 

1. Confidential Information 

A. Company Information. I agree at all times during the term of my employment and thereafter, to hold in strictest confidence, and not
to use, except for the benefit of the Company, or to disclose to any person, firm or corporation without written authorization of the Board of Directors of the Company, any Confidential Information of the Company, except under a non-disclosure
agreement duly authorized and executed by the Company. I understand that “Confidential Information” means any non-public information that relates to the actual or anticipated business or research and development of the Company, technical
data, trade secrets or know-how, including, but not limited to, research, product plans or other information regarding Company’s products or services and markets therefor, customer lists and customers (including, but not limited to, customers
of the Company on whom I called or with whom I became acquainted during the term of my employment), software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing,
finances, personnel-related data or information, or other business information. 
 B. Former Employer Information. I agree that I will
not, during my employment with the Company, improperly use or disclose any proprietary information or trade secrets of any former or concurrent employer or other person or entity and that I will not bring onto the premises of the Company any
unpublished document or proprietary information belonging to any such employer, person or entity unless consented to in writing by such employer, person or entity. 

C. Third Party Information. I recognize that the Company has received and in the future will receive from third parties their
confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. I agree to hold all such confidential or proprietary
information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out my work for the Company consistent with the Company’s agreement with such third party. 

2. Inventions. 
 A.
Inventions Retained and Licensed. I have attached hereto, as Exhibit A, a list describing all inventions, original works of authorship, developments, improvements, and trade secrets which were made by me prior to my employment
with the Company (collectively referred to as “Prior Inventions”), which belong to me, which relate to the Company’s proposed 







 
business, products or research and development, and which are not assigned to the Company hereunder; or, if no such list is attached, I represent that there are no such Prior Inventions. If in
the course of my employment with the Company, I incorporate into a Company product, process or service a Prior Invention owned by me or in which I have an interest, I hereby grant to the Company a nonexclusive, royalty-free, fully paid-up,
irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention as part of or in connection with such product, process or service, and to practice any method related thereto. 

B. Assignment of Inventions. I agree that I will promptly make full written disclosure to the Company, will hold in trust for the sole
right and benefit of the Company, and hereby assign to the Company, or its designee, all my right, title, and interest in and to any and all inventions, original works of authorship, developments, concepts, improvements, designs, discoveries, ideas,
trademarks or trade secrets, whether or not patentable or registrable under copyright or similar laws, which I may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the
period of time I am in the employ of the Company (collectively referred to as “Inventions”), except as provided in Section 3.F below. By my assignment, which the Company acknowledges and accepts, I also convey to the Company
the right to make applications in the Company’s own behalf for protection of such inventions, original works of authorship, developments, concepts, improvements, designs, discoveries, ideas, trademarks or trade secrets in the U.S. and countries
foreign to the U.S, and to claim priority to such applications that may be filed in the U.S. or any country foreign to the U.S. on the invention. I further acknowledge that all original works of authorship which are made by me (solely or jointly
with others) within the scope of and during the period of my employment with the Company and which are protectible by copyright are “works made for hire,” as that term is defined in the United States Copyright Act. I understand and agree
that the decision whether or not to commercialize or market any invention developed by me solely or jointly with others is within the Company’s sole discretion and for the Company’s sole benefit and that no royalty will be due to me as a
result of the Company’s efforts to commercialize or market any such invention. 
 C. Inventions Assigned to the United States. I
agree to assign to the United States government all my right, title, and interest in and to any and all Inventions whenever such full title is required to be in the United States by a contract between the Company and the United States or any of its
agencies. 
 D. Maintenance of Records. I agree to keep and maintain adequate and current written records of all Inventions made by me
(solely or jointly with others) during the term of my employment with the Company. The records will be in the form of notes, sketches, drawings, and any other format that may be specified by the Company. The records will be available to and remain
the sole property of the Company at all times. 
 E. Patent and Copyright Registrations. I agree to assist the Company, or its
designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries,
including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments which the Company shall deem necessary in order to
apply 

  
 2 








 
for and obtain such rights and in order to assign and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions, and
any copyrights, patents, mask work rights or other intellectual property rights relating thereto. I further agree that my obligation to execute or cause to be executed, when it is in my power to do so, any such instrument or papers shall continue
after the termination of this Agreement. If the Company is unable because of my mental or physical incapacity or for any other reason to secure my signature to apply for or to pursue any application for any United States or foreign patents or
copyright registrations covering Inventions or original works of authorship assigned to the Company as above, then I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact,
to act for and in my behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same legal force and
effect as if executed by me. 
 F. Exception to Assignments. I understand that the provisions of this Agreement requiring assignment
of Inventions to the Company do not apply to any invention which qualifies fully under the provisions of California Labor Code Section 2870 (attached hereto as Exhibit B). I will advise the Company promptly in writing of any inventions that I
believe meet the criteria in California Labor Code Section 2870 and not otherwise disclosed on Exhibit A. 
 3. Conflicting
Employment. I agree that, during the term of my employment with the Company, I will not engage in any other employment, occupation or consulting directly related to the business in which the Company is now involved or becomes involved during the
term of my employment, nor will I engage in any other activities that conflict with my obligations to the Company. 
 4. Returning
Company Documents. I agree that, at the time of leaving the employ of the Company or at any time prior upon Company request, I will deliver to the Company (and will not keep in my possession, recreate or deliver to anyone else) all Company
property including any and all devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings blueprints, sketches, materials, equipment, other documents or property, or reproductions of any aforementioned items
developed by me pursuant to my employment with the Company or otherwise belonging to the Company, its successors or assigns, including, without limitation, those records maintained pursuant to paragraph 3.D. In the event of the termination of
my employment, I agree to sign and deliver the “Termination Certification” attached hereto as Exhibit C. 
 5.
Notification of New Employer. In the event that I leave the employ of the Company, I hereby grant consent to notification by the Company to my new employer about my rights and obligations under this Agreement. 

6. Conflict of Interest Guidelines. I agree to diligently adhere to the Conflict of Interest Guidelines attached as
Exhibit D hereto. 
 7. Representations. I agree to execute any proper oath or verify any proper document required to
carry out the terms of this Agreement. I represent that my performance of 

  
 3 








 
all the terms of this Agreement will not breach any agreement to keep in confidence proprietary information acquired by me in confidence or in trust prior to my employment by the Company. I
hereby represent and warrant that I have not entered into, and I will not enter into, any oral or written agreement in conflict herewith. 

8. Availability of Injunctive Relief. BOTH PARTIES AGREE THAT ANY PARTY MAY PETITION A COURT FOR INJUNCTIVE RELIEF INCLUDING, BUT NOT
LIMITED TO, WHERE EITHER PARTY ALLEGES OR CLAIMS A VIOLATION OF THE AT-WILL EMPLOYMENT, CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT BETWEEN ME AND THE COMPANY OR ANY OTHER AGREEMENT REGARDING TRADE SECRETS, CONFIDENTIAL INFORMATION
OR LABOR CODE §2870. BOTH PARTIES UNDERSTAND THAT ANY BREACH OR THREATENED BREACH OF SUCH AN AGREEMENT WILL CAUSE IRREPARABLE INJURY AND THAT MONEY DAMAGES WILL NOT PROVIDE AN ADEQUATE REMEDY THEREFOR AND BOTH PARTIES HEREBY CONSENT TO THE
ISSUANCE OF AN INJUNCTION. 
 9. Voluntary Nature of Agreement. I ACKNOWLEDGE AND AGREE THAT I AM EXECUTING THIS AGREEMENT
VOLUNTARILY AND WITHOUT ANY DURESS OR UNDUE INFLUENCE BY THE COMPANY OR ANYONE ELSE. I FURTHER ACKNOWLEDGE AND AGREE THAT I HAVE CAREFULLY READ THIS AGREEMENT AND THAT I HAVE ASKED ANY QUESTIONS NEEDED FOR ME TO UNDERSTAND THE TERMS, CONSEQUENCES
AND BINDING EFFECT OF THIS AGREEMENT AND FULLY UNDERSTAND IT, FINALLY, I AGREE THAT I HAVE BEEN PROVIDED AN OPPORTUNITY TO SEEK THE ADVICE OF AN ATTORNEY OF MY CHOICE BEFORE SIGNING THIS AGREEMENT, 

10. General Provisions. 

A. Consent to Personal Jurisdiction. I hereby expressly consent to the personal jurisdiction of the state and federal courts located in
California for any lawsuit filed there against me by the Company arising from or relating to this Agreement. 
 B. Entire Agreement.
This Agreement sets forth the entire agreement and understanding between the Company and me relating to the subject matter herein and supersedes all prior discussions or representations between us including, but not limited to, any representations
made during my interview(s) or relocation negotiations, whether written or oral, No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing signed by the CEO of the
Company and me. Any subsequent change or changes in my duties, salary or compensation will not affect the validity or scope of this Agreement, I understand that nothing in this Agreement shall change or modify the at-will status of my employment
with the Company. 
 C. Severability. If one or more of the provisions in this Agreement are deemed void by law, then the remaining
provisions will continue in full force and effect. 

  
 4 








 D. Successors and Assigns. This Agreement will be binding upon my heirs, executors,
administrators and other legal representatives and will be for the benefit of the Company, its successors, and its assigns. 
  

							
	Date:	 	6/15/2015	 		 	/s/ Robert E. Hoffman
		 		 		 	Signature
				
	  
	 		 	  
	 	Robert E. Hoffman
		 		 		 	Name of Employee (typed or printed)


  
 5 








 Exhibit A 

LIST OF PRIOR INVENTIONS 
 AND ORIGINAL WORKS OF AUTHORSHIP 

 

					
	 Title
	 	 Date
	 	 Identifying Number or Brief

Description


  

	X	No inventions or improvements 

  

	    	Additional Sheets Attached 

  

			
	Signature of Employee:	 	/s/ Robert E. Hoffman


			
		
	Print Name of Employee:	 	Robert E. Hoffman


			
		
	Date:	 	June 15, 2015


  
 6 








 Exhibit B 

CALIFORNIA LABOR CODE SECTION 2870 
 INVENTION ON OWN
TIME-EXEMPTION FROM AGREEMENT 
 “(a) Any provision in an employment agreement which provides that an employee shall assign, or
offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade
secret information except for those inventions that either: 
 (1) Relate at the time of conception or reduction to practice of the invention
to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or 
 (2) Result from any
work performed by the employee for the employer. 
 (b) To the extent a provision in an employment agreement purports to require an employee
to assign an invention otherwise excluded from being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.” 

  
 7 








 Exhibit C 

AnaptysBio, Inc. 
 TERMINATION CERTIFICATION 

This is to certify that I do not have in my possession, nor have I failed to return, any devices, records, data, notes, reports, proposals,
lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment, other documents or property, or reproductions of any aforementioned items belonging to AnaptyBio, Inc., its subsidiaries, affiliates, successors or assigns
(together, the “Company”). 
 I further certify that I have complied with all the terms of the Company’s Employment,
Confidential Information and Invention Assignment Agreement signed by me, including the reporting of any inventions and original works of authorship (as defined therein), conceived or made by me (solely or jointly with others) covered by that
agreement. 
 I further agree that, in compliance with the Employment, Confidential Information and Invention Assignment Agreement, I will
preserve as confidential all trade secrets, confidential knowledge, data or other proprietary information relating to products, processes, know-how, designs, formulas, developmental or experimental work, computer programs, data bases, other original
works of authorship, customer lists, business plans, financial information or other subject matter pertaining to any business of the Company or any of its employees, clients, consultants or licensees. 

 

			
	Date:	 	 

  

	
	   

	(Employee’s Signature)
	
	   

	Type/Print Employee’s Name)



  
 8 








 Exhibit D 

AnaptysBio, Inc. 
 CONFLICT OF INTEREST GUIDELINES

 It is the policy of AnaptysBio, Inc, to conduct its affairs in strict compliance with the letter and spirit of the law and to adhere
to the highest principles of business ethics. Accordingly, all officers, employees and independent contractors must avoid activities which are in conflict, or give the appearance of being in conflict, with these principles and with the interests of
the Company. The following are potentially compromising situations which must be avoided. Any exceptions must be reported to the President and written approval for continuation must be obtained. 

 

	 	1.	Revealing confidential information to outsiders or misusing confidential information. Unauthorized divulging of information is a violation of this policy whether or not for personal gain and whether or not harm to the
Company is intended. (The Employment, Confidential Information, and Invention Assignment Agreement elaborates on this principle and is a binding agreement.) 

  

	 	2.	Accepting or offering substantial gifts, excessive entertainment, favors or payments which may be deemed to constitute undue influence or otherwise be improper or embarrassing to the Company. 


 

	 	3.	Participating in civic or professional organizations that might involve divulging confidential information of the Company. 

  

	 	4.	Initiating or approving personnel actions affecting reward or punishment of employees or applicants where there is a family relationship or is or appears to be a personal or social involvement. 


 

	 	5.	Initiating or approving any form of personal or social harassment of employees. 

  

	 	6.	Investing or holding outside directorship in suppliers, customers, or competing companies, including financial speculations, where such investment or directorship might influence in any manner a decision or course of
action of the Company. 

  

	 	7.	Borrowing from or lending to employees, customers or suppliers. 

  

	 	8.	Acquiring real estate of interest to the Company. 

  

	 	9.	Improperly using or disclosing to the Company any proprietary information or trade secrets of any former or concurrent employer or other person or entity with whom obligations of confidentiality exist.


  

	 	10.	Unlawfully discussing prices, costs, customers, sales or markets with competing companies or their employees. 


  
 9 









	 	11.	Making any unlawful agreement with distributors with respect to prices. 

  

	 	12.	Improperly using or authorizing the use of any inventions which are the subject of patent claims of any other person or entity. 

  

	 	13.	Engaging in any conduct which is not in the best interest of the Company. 

 Each officer,
employee and independent contractor must take every necessary action to ensure compliance with these guidelines and to bring problem areas to the attention of higher management for review. Violations of this conflict of interest policy may result in
discharge without warning. 

  
 10